Aurobindo Pharma Share Buyback, Aurobindo Pharma Buyback Price:Aurobindo Pharma on Monday (April 6) has announced a share buyback programme. Subject to required approvals from regulatory and/or statutory authorities under applicable laws, the company will buy back up to 54,23,728 fully paid-up equity shares of face value INR 1 each. These shares represent up to 0.93% of the total paid-up equity share capital.
A share buyback, or share repurchase, is a corporate action where a company buys back its own outstanding shares from existing shareholders, reducing the number of shares available in the market.
This buyback size accounts for 3.93% of the aggregate of total paid-up equity share capital and free reserves (including securities premium) as per the latest audited standalone financial statements, and 2.62% as per the consolidated financial statements, both as at March 31, 2025.
“Subject to such approvals of regulatory and/or statutory authorities as may be required under applicable laws, the buyback of up to 54,23,728 (Fifty four lakhs twenty three thousand seven hundred and twenty eight only) fully paid-up equity shares of the Company, each having a face value of INR 1/- (Indian Rupee one only) (“Equity Shares”), representing up to 0.93% of the total number of equity shares in the paid-up equity share capital of the Company, at a price of INR 1,475/- (Indian Rupees one thousand four hundred and seventy five only) per Equity Share (“Buyback Price”) payable in cash for an aggregate amount up to INR 800,00,00,000/-(Indian Rupees eight hundred crores only) (“Buyback Size”) being 3.93% and 2.62% of the aggregate of the total paid-up equity share capital and free reserves (including securities premium) as per the latest audited standalone and consolidated financial statements of the Company as at March 31, 2025, respectively,” the company informed in its April 6 dated exchange filing.
Aurobindo Pharma Buyback Record Date
“April 17, 2026 (“Record Date”) as the record date for the purpose of determining the entitlement and the names of equity shareholders who would be eligible to participate in the buyback, in accordance with Regulation 42 of the Listing Regulations and Regulation 9(i) of the Buyback Regulations,” the filing added.
Notably, the buyback size does not include transaction costs viz. brokerage costs, fees, turnover charges, applicable taxes on this, securities transaction tax, goods and services tax, stamp duty, etc., and expenses incurred or to be incurred for the buyback like filing fees payable to the SEBI, advisors/ legal fees, public announcement publication expenses, printing and dispatch expenses and other incidental and related expenses, etc.
